Page 51 - Power of Stem Cells- arthritis and regeneration
P. 51
Luque-Campos et al. MSCs and Memory T Cells in RA
(CD127), allowing consistent identification and sorting of live cells. J with early rheumatoid arthritis and poor prognostic factors. Ann Rheum Dis.
Immunol Methods. (2007) 319:41–52. doi: 10.1016/j.jim.2006.10.008 (2009) 68:1870–7. doi: 10.1136/ard.2008.101121
115. Wang W, Shao S, Jiao Z, Guo M, Xu H, Wang S. The Th17/Treg 133. Cribbs AP, Kennedy A, Penn H, Read JE, Amjadi P, Green P, et al. Treg
imbalance and cytokine environment in peripheral blood of patients cell function in rheumatoid arthritis is compromised by CTLA-4 promoter
with rheumatoid arthritis. Rheumatol Int. (2012) 32:887–93. doi: 10.1007/ methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase
s00296-010-1710-0 pathway: defective treg cell function in RA and the IDO pathway. Arthritis
116. Niu Q, Cai B, Huang Z, Shi Y, Wang L. Disturbed Th17/Treg balance Rheumatol. (2014) 66:2344–54. doi: 10.1002/art.38715
in patients with rheumatoid arthritis. Rheumatol Int. (2012) 32:2731–6. 134. Koenen HJPM, Smeets RL, Vink PM, van Rijssen E, Boots
doi: 10.1007/s00296-011-1984-x AMH, Joosten I. Human CD25highFoxp3pos regulatory T cells
117. Eggleton P, Bremer E, Tarr JM, de Bruyn M, Helfrich W, Kendall A, et al. differentiate into IL-17-producing cells. Blood. (2008) 112:2340–52.
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid doi: 10.1182/blood-2008-01-133967
arthritis patients is higher compared to healthy subjects. Arthritis Res Ther. 135. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille
(2011) 13:R208. doi: 10.1186/ar3541 JJ, et al. The orphan nuclear receptor RORγt directs the differentiation
118. Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial program of proinflammatory IL-17+ T helper cells. Cell. (2006) 126:1121–
fluid levels of interleukin-17 in correlation with disease activity in 33. doi: 10.1016/j.cell.2006.07.035
patients with RA. Clin Rheumatol. (2011) 30:1201–7. doi: 10.1007/ 136. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al.
s10067-011-1737-y Functional delineation and differentiation dynamics of human CD4+ T cells
119. Kim J, Kang S, Kim J, Kwon G, Koo S. Elevated levels of T helper 17 cells are expressing the FoxP3 transcription factor. Immunity. (2009) 30:899–911.
associated with disease activity in patients with rheumatoid arthritis. Ann doi: 10.1016/j.immuni.2009.03.019
Lab Med. (2013) 33:52–9. doi: 10.3343/alm.2013.33.1.52 137. Ghannam S, Pene J, Torcy-Moquet G, Jorgensen C, Yssel H. Mesenchymal
120. Benedetti G, Miossec P. Interleukin 17 contributes to the chronicity of stem cells inhibit human Th17 cell differentiation and function and
inflammatory diseases such as rheumatoid arthritis: HIGHLIGHTS. Eur J induce a T regulatory cell phenotype. J Immunol. (2010) 185:302–12.
Immunol. (2014) 44:339–47. doi: 10.1002/eji.201344184 doi: 10.1371/journal.pone.0045272
121. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, 138. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, et al. Human
et al. Human interleukin-17: a T cell-derived proinflammatory cytokine leukocyte antigen-G5 secretion by human mesenchymal stem cells is
produced by the rheumatoid synovium. Arthritis Rheum. (1999) 42:963–70. required to suppress T lymphocyte and natural killer function and to induce
doi: 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E CD4 CD25 high FOXP3 + regulatory T cells. Stem Cells. (2008) 26:212–22.
+
122. Honorati MC, Meliconi R, Pulsatelli L, Canè S, Frizziero L, Facchini A. High doi: 10.1634/stemcells.2007-0554
in vivo expression of interleukin-17 receptor in synovial endothelial cells 139. Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, Le Blanc
and chondrocytes from arthritis patients. Rheumatology. (2001) 40:522–7. K. The impact of inflammatory licensing on heme oxygenase-1-mediated
doi: 10.1093/rheumatology/40.5.522 induction of regulatory T cells by human mesenchymal stem cells. Blood.
123. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, (2011) 117:4826–35. doi: 10.1182/blood-2010-12-324038
et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed 140. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact,
joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. prostaglandin E 2 and transforming growth factor beta 1 play non-redundant
(2007) 204:2803–12. doi: 10.1084/jem.20071397 roles in human mesenchymal stem cell induction of CD4+ CD25 High
124. Sundrud MS, Trivigno C. Identity crisis of Th17 cells: many forms, forkhead box P3+ regulatory T cells. Clin Exp Immunol. (2009) 156:149–60.
many functions, many questions. Semin Immunol. (2013) 25:263–72. doi: 10.1111/j.1365-2249.2009.03874.x
doi: 10.1016/j.smim.2013.10.021 141. Gonzalez-Rey E, Gonzalez MA, Varela N, O’Valle F, Hernandez-Cortes
125. Jiao Z, Wang W, Jia R, Li J, You H, Chen L, et al. Accumulation of FoxP3- P, Rico L, et al. Human adipose-derived mesenchymal stem cells
expressing CD4+ CD25+ T cells with distinct chemokine receptors in reduce inflammatory and T cell responses and induce regulatory T
synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol. cells in vitro in rheumatoid arthritis. Ann Rheum Dis. (2010) 69:241–8.
(2007) 36:428–33. doi: 10.1080/03009740701482800 doi: 10.1136/ard.2008.101881
126. van Amelsfort JMR, Jacobs KMG, Bijlsma JWJ, Lafeber FPJG, Taams 142. Lee H-J, Kim S-N, Jeon M-S, Yi T, Song SU. ICOSL expression in
LS. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences human bone marrow-derived mesenchymal stem cells promotes induction
in the presence, phenotype, and function between peripheral blood of regulatory T cells. Sci Rep. (2017) Dec 7:44486. doi: 10.1038/srep44486
and synovial fluid. Arthritis Rheum. (2004) 50:2775–85. doi: 10.1002/ 143. Luz-Crawford P, Espinosa-Carrasco G, Ipseiz N, Contreras R, Tejedor G,
art.20499 Medina DA, et al. Gilz-Activin A as a novel signaling axis orchestrating
127. Walter GJ, Fleskens V, Frederiksen KS, Rajasekhar M, Menon B, Gerwien mesenchymal stem cell and Th17 cell interplay. Theranostics. (2018) 8:846–
JG, et al. Phenotypic, functional, and gene expression profiling of peripheral 59. doi: 10.7150/thno.21793
CD45RA+ and CD45RO+ CD4+CD25+CD127 low treg cells in patients 144. Diianni M. Mesenchymal cells recruit and regulate T regulatory cells. Exp
with chronic rheumatoid arthritis: peripheral Treg cells in chronic RA. Hematol. (2008) 36:309–18. doi: 10.1016/j.exphem.2007.11.007
Arthritis Rheumatol. (2016) 68:103–16. doi: 10.1002/art.39408 145. Franceschetti T, De Bari C. The potential role of adult stem cells in the
128. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, management of the rheumatic diseases. Ther Adv Musculoskel Dis. (2017)
et al. Compromised function of regulatory T cells in rheumatoid arthritis 9:165–79. doi: 10.1177/1759720X17704639
and reversal by anti-TNFα therapy. J Exp Med. (2004) 200:277–85.
doi: 10.1084/jem.20040165 Conflict of Interest Statement: The authors declare that the research was
129. Valencia X. TNF downmodulates the function of human CD4+CD25hi T- conducted in the absence of any commercial or financial relationships that could
regulatory cells. Blood. (2006) 108:253–61. doi: 10.1182/blood-2005-11-4567 be construed as a potential conflict of interest.
130. Zanin-Zhorov A, Ding Y, Kumari S, Attur M, Hippen KL,
Brown M, et al. Protein kinase C- mediates negative feedback on Copyright © 2019 Luque-Campos, Contreras-López, Jose Paredes-Martínez, Torres,
regulatory T cell function. Science. (2010) 328:372–6. doi: 10.1126/ Bahraoui, Wei, Espinoza, Djouad, Elizondo-Vega and Luz-Crawford. This is an
science.1186068 open-access article distributed under the terms of the Creative Commons Attribution
131. Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, et al. Phosphorylation of FOXP3 License (CC BY). The use, distribution or reproduction in other forums is permitted,
controls regulatory T cell function and is inhibited by TNF-α in rheumatoid provided the original author(s) and the copyright owner(s) are credited and that the
arthritis. Nat Med. (2013) 19:322–8. doi: 10.1038/nm.3085 original publication in this journal is cited, in accordance with accepted academic
132. Westhovens R, Robles M, Ximenes AC, Nayiager S, Wollenhaupt J, Durez P, practice. No use, distribution or reproduction is permitted which does not comply
et al. Clinical efficacy and safety of abatacept in methotrexate-naive patients with these terms.
Frontiers in Immunology | www.frontiersin.org 11 April 2019 | Volume 10 | Article 798